by Jordana Choucair | Dec 8, 2021 | Payers
A Kaiser Family Foundation county-by-county analysis found that premiums for the ACA Marketplace benchmark silver plan are decreasing for the fourth year in a row. Across counties, average premiums before tax credits fell 1.8 percent for the lowest-cost silver plan...
by Jordana Choucair | Dec 7, 2021 | Transition to Value
A report from consulting firm Mathematica found that the Independence at Home model hasn’t meaningfully improved primary care at home or curbed program costs. The report contradicts CMS, which has reported savings since the project launched six years ago....
by Jordana Choucair | Dec 7, 2021 | Public Health/Prevention
The seven-day average for vaccinations in the U.S. reached about 1.8 million on Monday, up from an average of about 1.3 million a month ago. Much of the growth is attributed to people getting boosters, rather than unvaccinated people seeking their first shots. About...
by Jordana Choucair | Dec 7, 2021 | Opioid/Substance Use Disorders
Representative Donald Norcross and Senator Ed Markey announced legislation Monday that would expand access to opioid medication. The Opioid Treatment Access Act targets restrictions on methadone. The bill specifically would make the easing of restrictions approved...
by Jordana Choucair | Dec 7, 2021 | Life Sciences
USAID said it is launching a new $400 million program to help speed COVID-19 vaccinations in lower-income countries. Most of the funding will go toward helping the countries with policy, supply chain logistics, and administering the shots in remote areas. The rest...
by Jordana Choucair | Dec 7, 2021 | Life Sciences
GlaxoSmithKline Plc said research shows its COVID-19 antibody treatment is effective against the full combination of mutations in the new omicron variant. Tests done in-vitro against a pseudo-virus that recreates a synthesized version of omicron showed that...
Recent Comments